Changing Course: statewide efforts to combat the opioid epidemic in California

Size: px
Start display at page:

Download "Changing Course: statewide efforts to combat the opioid epidemic in California"

Transcription

1 Changing Course: statewide efforts to combat the opioid epidemic in California Kelly Pfeifer, MD April 26, 2018 State of Reform conference

2 STAT Special Report: 52 weeks, 52 faces Obituaries narrate lives lost to the opioid epidemic More people die from alcohol and tobacco use, but neither is likely to kill you tonight. Opioid overdose robs decades from young lives. California Health Care Foundation 2

3 Four Strategies to Lower Death Rates 1. PREVENT 2. MANAGE Prevent new starts on long-term opioid use. Manage chronic pain safely, focusing on highest risk: high dose, opioids + sedatives. 3. TREAT 4. STOP California Health Care Foundation Treat addiction effectively: medications for addiction treatment (MAT). Stop deaths with harm reduction: naloxone needle exchanges supervised injection sites 3

4 How are we doing? California Health Care Foundation 4

5 California Health Care Foundation 5

6 PREVENT: MME = morphine mg equivalents Total opioids prescribed Rationale: Risk of prolonged use: ^ by 1% per day > 3d Source: California Opioid Overdose Surveillance Dashboard: Day 5 Day 30 Source: Pain Medicine, Volume 17, Issue 1, 1 January 2016,

7 MANAGE: People on high-dose opioids (MME = morphine mg equivalents) MME = morphine mg equivalents Rationale: Fatal ODs: 9x with high-dose 10x with opioids+benzos Source: California Opioid Overdose Surveillance Dashboard: 9x death rate >120 MME 10x death rate when 10x benzos death added rate to opioids with benzos Source: Dasgupta N, Funk MJ, Proescholdbell S, Hirsch A, Ribisl KM, Marshall S. Cohort Study of the Impact of High-dose Opioid Analgesics on Overdose Mortality. Pain Med 2016; 17:85-98

8 TREAT: Total buprenorphine prescriptions (MME = morphine mg equivalents) Rationale: Source: California Opioid Overdose Surveillance Dashboard (rates per 100k): Maintenance drops OD deaths Maintenance Detox 3x death rate after methadone detox 2x death rate after buprenorphine detox Maintenance Detox Methadone Buprenorphine Sordo et al., Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies, BMJ 2017; 357;j1550

9 STOP DEATHS: Alarming Fentanyl Trends California Health Care Foundation Source: California Opioid Overdose Surveillance Dashboard: 9

10 We have a long way to go. California Health Care Foundation 10

11 Treatment needs to be easier to access than street drugs. Brain in a tempest: Addiction means day-to-day survival MAT stabilizes brain chemistry: Ability to focus on recovery Treatment success at 12 months: Treatment with medications* Methadone: 74-80% Buprenorphine (Suboxone): 60-90% Naltrexone (Vivitrol**): 10-31%** Treatment without medications: 6% *Based on meta-analyses of research studies; rates of success lower in real-world settings **Most Vivitrol studies done for 3-6 months; 12-month registry study only had % discontinued due to meeting goals Source: California Health Care Foundation, Why Health Plans Should go to the MAT in the Fight Against Opioid Addiction 10 California Health Care Foundation 11

12 How Much MAT Do You Need? Snapshots by county available at California Health Care Foundation 12

13 California Opioid Safety Network Local leaders coming together to fight the epidemic, connected across the state Leaders: medical societies, county leaders, public health, hospitals, and others. Participants: Bringing together medical providers, pharmacies, law enforcement and corrections, advocates, consumers and families, addiction treatment, health plans, and others. Priorities: Opioid over-prescribing Access to addiction treatment Naloxone and harm reduction California Health Care Foundation 13

14 California s Coordinated Campaigns Addiction treatment expansion programs California Health Care Foundation Statewide Opioid Safety (SOS) Workgroup 14

15 What Can We Learn from Another Epidemic? US AIDS Deaths, Effective medications. Massive effort to increase access. Anti-stigma campaign. --- AIDS deaths Source: Centers for Disease Control, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention California Health Care Foundation 15

16 The French Experience: 80% Drop in Deaths Heroin OD deaths Buprenorphine prescriptions Methadone treatment California Health Care Foundation 16

17 Every Door Is the Right Door Homeless Services Smart Care CA SUD treatment system Treating Addiction In Primary Care MAT-ED Pharmacies Project SHOUT California Health Care Foundation Jails and Prisons Rhode Island: access to Tx for all 61% drop in post-incarceration OD deaths with jail MAT 17

18 Questions California Health Care Foundation Kelly Pfeifer, MD 18

19 Narcotic Safety Initiative A health plan response to the opioid epidemic Salina Wong, PharmD Director Clinical Pharmacy Programs Blue Shield of California April 26, 2018 State of Reform conference

20 Blue Shield of California s Goal Three-year goal to decrease opioid use by 50% among Blue Shield members with non-cancer pain by the end of 2018 Blue Shield of California 20

21 people on chronically high doses of opioids prevent progression to chronic use for members newly starting opioids prescriptions and refills for members newly starting opioid through evidence-based interventions Prudent prescribing and proactive management Access to programs to manage pain, addiction, and substance abuse Diligence on fraud, waste, and abuse Enhanced coverage policies and formulary management Blue Shield of California 21

22 Blue Shield of CA Board of Directors review and approval Restrict extendedrelease opioids Narcotic case management Provider awareness Limit high dose prescribing Prevent stockpiling Prevent extended use for acute pain Pharmacomedical analyses Enhanced opioid reporting to prescribers Public awareness Senate HELP Committee briefing CHCF case study Safe Med LA Medication Assisted Therapy (MAT) Limit overprescribing for acute pain, cough, cold Prescriber education/ training Chronic pain management program Blue Shield of California 22

23 Collaborating with Providers 1. Education and training 2. Clinical rounds with multi-disciplinary team and specialty expertise 3. Patient education: 6-8 week class 4. In-house pain & opioid use disorder (OUD) specialists for easy/fast referral 5. Policies/procedures, pain contracts, urine testing 6. Shared decision-making, risk assessments 7. Pain assessment protocols deployed by pharmacist providers during patient appointments, shared with physician, including medication recommendations Blue Shield of California 23

24 Our progress 18% 42% Blue Shield of California 24

25 Challenges and Opportunities 1. Awareness and action by all prescriber types & pharmacists, in all settings 2. Differentiation of pain specialists based on opioid prescribing practices 3. Identifying evidence-based treatment programs 4. Access to behavioral health services 5. Expanding primary care management of opioid use disorder 6. Insurance fraud Blue Shield of California 25

26 Making a difference Covered CA member Helped by narcotic case management 56 yr. old female with lupus and chronic pain syndrome Out-of-network prescriber 550 mg morphine equivalent dose (MED): meperidine 300 mg/day hydromorphone 4mg 10x per day fentanyl up to150mcg every 48 hrs Now member is seeing an in-network provider and only taking hydromorphone 16 mg/day. MED = 64 88% reduction in daily opioid dose! Blue Shield Prescriber reports working Blue Shield provider called specifically to let us know about a 64 yr. old member on a holy trinity combination with opioid Rx, identified in the Blue Shield report mailed to his office. Prescriber stopped two of the medications (benzodiazepine and muscle relaxant). He had been meaning to do this for some time, but the report provided good motivation to discontinue these medications. Blue Shield of California 26

27 Why it matters Referred to substance abuse treatment Medicare PDP member with thoracic spinal pain with total opioid doses up to 800 MED. Left Blue Shield Nov. 2015, but returned Now managed by a new provider and tapered down to 50 MED and in substance abuse treatment on buprenorphine. >90% reduction in daily opioid dose! Accountable Care (ACO) partnership driving change Member with an ACO primary care physician identified using compounded hydromorphone injectable plus many other opioid Rx s written by an out-of-network provider. Blue Shield pharmacist + ACO pharmacist worked together to discontinue compounded hydromorphone and taper utilization of other opioids, dropping MED by 50%. Repatriated member back into ACO to manage & coordinate care. Blue Shield of California 27

28 OPIOIDS: THE SYSTEM GENERATED AMERICAN EPIDEMIC Health and Human Services Agency Dr. Nicole Esposito - Behavioral Health Services - Assistant Medical Director 28

29 SAN DIEGO COUNTY MEDICAL EXAMINER REPORT ( ) UNINTENTIONAL DEATHS DUE TO DRUG/MEDICATION TYPE 29

30 PAIN MANAGEMENT PRACTICES 30

31 RESPONSE FROM HEALTHCARE PROVIDERS Improved Quality of Care: Better pain management practices Better identification of addiction Gaps Still Remained: Poor access to integrated approaches to pain management Poor access to SUD treatment

32 DRUG MEDI-CAL ORGANIZED DELIVERY SYSTEM Case Management Recovery Residences Withdrawal Management Medication Assisted Treatment Network Adequacy

33 LINKING CARE: DMC-ODS JUSTICE SYSTEM PRIMARY CARE MENTAL HEALTH SYSTEMS Recovery Residence Withdrawal Mgmt. ACUTE CARE HOSPITALS EMERGENCY DEPARTMENTS Treatment Programs SOCIAL SERVICES

34 MOVING FORWARD Build system capacity Information sharing Provider to Provide communication 34

35 DMC-ODS QUESTIONS/COMMENTS? 35

36 Questions & Discussion Kelly Pfeifer, MD Nicole Esposito, MD Salina Wong, PharmD California Health Care Foundation 36

Mobilizing a Response to the Opioid Epidemic: County Snapshots. Kelly Pfeifer, MD May 10, 2018

Mobilizing a Response to the Opioid Epidemic: County Snapshots. Kelly Pfeifer, MD May 10, 2018 Mobilizing a Response to the Opioid Epidemic: County Snapshots Kelly Pfeifer, MD kpfeifer@chcf.org May 10, 2018 Housekeeping All lines are muted This session will be recorded To ask a question: Questions

More information

Narcotics Safety Initiative opioid overuse, chronic pain, and what Plans can do about it

Narcotics Safety Initiative opioid overuse, chronic pain, and what Plans can do about it Narcotics Safety Initiative opioid overuse, chronic pain, and what Plans can do about it Marcus Thygeson, MD, MPH Chief Health Officer, SVP Healthcare Services Blue Shield of California Celebrities who

More information

What would it take to get to zero overdose deaths in California? Kelly Pfeifer, MD May 5, 2017

What would it take to get to zero overdose deaths in California? Kelly Pfeifer, MD May 5, 2017 What would it take to get to zero overdose deaths in California? Kelly Pfeifer, MD kpfeifer@chcf.org May 5, 2017 Beth Name and picture changed What we believed then Opioids are safer than alternatives

More information

Smart Care California: Multi-Stakeholder Strategies for Reducing Opioid Overuse. Jennifer Wong, MPH IHA Stakeholders Meeting September 19, 2017

Smart Care California: Multi-Stakeholder Strategies for Reducing Opioid Overuse. Jennifer Wong, MPH IHA Stakeholders Meeting September 19, 2017 Smart Care California: Multi-Stakeholder Strategies for Reducing Opioid Overuse Jennifer Wong, MPH IHA Stakeholders Meeting September 19, 2017 Why Measure Opioid Use? NATIONAL EPIDEMIC 400% Increase in

More information

SUBSTANCE USE DISORDER TREATMENT AND REFERRAL PROCESS

SUBSTANCE USE DISORDER TREATMENT AND REFERRAL PROCESS SUBSTANCE USE DISORDER TREATMENT AND REFERRAL PROCESS Presented by: John M. Connolly, Ph.D. Acting Deputy Director Los Angeles County Health Agency Department of Public Health Substance Abuse Prevention

More information

Closing the Loop in Treating Opioid Addiction:

Closing the Loop in Treating Opioid Addiction: Closing the Loop in Treating Opioid Addiction: Integrating MAT into Prison and Jail Health Systems May 9, 2018 Webinar Housekeeping All lines are muted This session will be recorded To ask a question:

More information

Aetna s Initiative on the Opioid Epidemic

Aetna s Initiative on the Opioid Epidemic Aetna s Initiative on the Opioid Epidemic Christopher James D.O., M.P.H. Medical Director, BH- Mid-Atlantic Territory (JamesC1@aetna.com) July 23, 2017 HHS Data on Epidemic Every Day in the U.S. More than

More information

Opioid Task Force Kick-Off Meeting. February 29, 2016

Opioid Task Force Kick-Off Meeting. February 29, 2016 Opioid Task Force Kick-Off Meeting February 29, 2016 Scope of the Opioid Problem and Data Review Olivia Kasirye, MD, MS County Public Health Officer OVERVIEW The Opioid Epidemic Opioid Task Force Development

More information

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention

Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention The Accountable Community for Health of King County Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention May 7, 2018 1 Opiate Treatment & Overdose Prevention Project Goal Immediate:

More information

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD

Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse. Jill M Williams, MD Academic Medical School: Implementing Curriculum in Chronic Pain and Opioid Misuse Pain, Pain Management and the Opioid Epidemic Symposium Jill M Williams, MD Professor Psychiatry Director, Division Addiction

More information

What is the strategy?

What is the strategy? What is the strategy? Multi-pronged approaches to reducing the health consequences of opioid use, New York City Northeast Epidemiology Conference Public health approach Track drug use and associated health

More information

Opioid Prescribing Improvement Program

Opioid Prescribing Improvement Program Opioid Prescribing Improvement Program Jeff Schiff, MD, MBA, Medical Director of Minnesota Health Care Programs Sarah Rinn, MPH, Opioid Prescribing Improvement Program Coordinator Agenda Opioid Prescribing

More information

Medication Assisted Treatment

Medication Assisted Treatment Meeting the Needs of Your Clients: Building Competencies in Mental Health and Addiction Services Medication Assisted Treatment November 5, 2018 In partnership with: House Keeping Because this is a webinar,

More information

Addressing the Opioid Epidemic in Tennessee

Addressing the Opioid Epidemic in Tennessee Addressing the Opioid Epidemic in Tennessee A Multidisciplinary Approach Melissa McPheeters, PhD, MPH Director, Informatics and Public Health Analytics 26 108 733 *Source: CDC References Centers for

More information

Kentucky s Plan to Address the Opioid Crisis National Statistics. Scope of the Problem 3/14/18

Kentucky s Plan to Address the Opioid Crisis National Statistics. Scope of the Problem 3/14/18 Kentucky s Plan to Address the Opioid Crisis Dr. Katherine Marks Critical Access Hospital Substance Abuse Summit March 8, 2018 2016 National Statistics Deaths per 100,000 population 25 20 15 10 5 Scope

More information

Opioid Misuse and Overdose Prevention and Safety. Dr. Kathleen Clanon Medical Director May 31, 2018

Opioid Misuse and Overdose Prevention and Safety. Dr. Kathleen Clanon Medical Director May 31, 2018 Opioid Misuse and Overdose Prevention and Safety Dr. Kathleen Clanon Medical Director May 31, 2018 1 On average, 115 Americans die every day from an opioid overdose. Centers for Disease Control 2 Opioid

More information

State Opioid Response (SOR) Grant

State Opioid Response (SOR) Grant State Opioid Response (SOR) Grant Adam Bucon, LSW DMHAS Provider Meeting September 20, 2018 Philip D. Murphy Governor Shereef M. Elnahal Commissioner Sheila Y. Oliver Lt. Governor NJ Opioid Statistics

More information

Understanding and Combating the Heroin Epidemic

Understanding and Combating the Heroin Epidemic Understanding and Combating the Heroin Epidemic Kelly Dunn, Ph.D. Assistant Professor; Johns Hopkins School of Medicine Department of Psychiatry and Behavioral Sciences 1 Talk Outline What is causing the

More information

Prescription Opioid Overdose in Oregon: A public health perspective

Prescription Opioid Overdose in Oregon: A public health perspective Prescription Opioid Overdose in Oregon: A public health perspective Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Oregon Health Authority All-Cause Mortality,

More information

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. 2017 State Targeted Response to the Opioid Crisis Grants QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. H.R.6-21st Century Cures Act The 21st Century Cures Act is a United States law enacted

More information

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.

Working with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m. Working with People Who Use Drugs in HIV Care Settings August 29, 2017 Workshop C 2:00 3:30 p.m. Working with People Who Use Drugs in HIV Care Settings Facilitator: Liz Hall, CDPH Office of AIDS Matt Curtis,

More information

OPIOID WORKGROUP LEADERSHIP TEAM

OPIOID WORKGROUP LEADERSHIP TEAM OPIOID WORKGROUP LEADERSHIP TEAM Community-wide Action Plan and Call to Action This brief summary of the Opioid Action Plan presented to the Skagit County Board of Health on December 13, 2016 provides

More information

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS Challenges and Opportunities Providing Medication Assisted Treatment (Buprenorphine) August 18, 2016 SPEAKERS TODAY Nilesh Kalyanaraman, MD, Chief Health

More information

FOR IMMEDIATE RELEASE MARCH

FOR IMMEDIATE RELEASE MARCH FOR IMMEDIATE RELEASE MARCH 20, 2018 Contact: Jeff Washington, Deputy Executive Director, ACA, Alexandria, VA jeffw@aca.org 703-224-0103 Contact: Bob Davis, VP, Marketing, Membership & Engagement, ASAM,

More information

RI Centers of Excellence for the

RI Centers of Excellence for the RI Centers of Excellence for the Treatment of Opioid Use Disorder COE CODAC Behavioral Healthcare Linda Hurley President/CEO 9-18-17 for the Warren Alpert Medical School of Brown University RI s Strategic

More information

Battling Opioid Addiction: Public Policy and Healthcare Strategies for an Epidemic

Battling Opioid Addiction: Public Policy and Healthcare Strategies for an Epidemic Battling Opioid Addiction: Public Policy and Healthcare Strategies for an Epidemic Speakers: Margarita Pereyda, M.D., Principal, Moderator: Carl Mercurio, Information Services September 29, 2015 HealthManagement.com

More information

8/16/2018. California s MAT Expansion Hub and Spoke System: Provider and Consumer Perspectives. Agenda. No Wrong Door

8/16/2018. California s MAT Expansion Hub and Spoke System: Provider and Consumer Perspectives. Agenda. No Wrong Door California s MAT Expansion Hub and Spoke System: Provider and Consumer Perspectives Gloria Miele, PhD, Learning Collaborative Coordinator, Hub and Spoke MAT Expansion Project Richard Rawson, PhD, Professor

More information

The Opioid Epidemic: The State of the State

The Opioid Epidemic: The State of the State JOINT LEGISLATIVE COMMITTEE ON HEALTH AND HUMAN SERVICES The Opioid Epidemic: The State of the State Dr. Mandy Cohen, Dr. Susan Kansagra Department of Health and Human Services Nov. 14, 2017 3 PEOPLE DIE

More information

PROJECT DOVE. Improving Maternal and Neonatal Health Through Safer Opioid Prescribing

PROJECT DOVE. Improving Maternal and Neonatal Health Through Safer Opioid Prescribing PROJECT DOVE Improving Maternal and Neonatal Health Through Safer Opioid Prescribing PARTNERS SUPPORT Bureau of Justice Assistance, Department of Justice Rhode Island Opportunity Non-medical prescription

More information

Successful Prevention Strategies to Address the Opioid Crises

Successful Prevention Strategies to Address the Opioid Crises Successful Prevention Strategies to Address the Opioid Crises Shannon Breitzman, MSW, Principal Denver Office Lindsey Kato, MPH, CHES, Consultant Denver Office 1 LEARNING OBJECTIVES + Find out how to effectively

More information

Opiate Use Disorder and Opiate Overdose

Opiate Use Disorder and Opiate Overdose Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5

More information

Massachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs. Monica Bharel, MD MPH Commissioner of Public Health

Massachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs. Monica Bharel, MD MPH Commissioner of Public Health Massachusetts Responds to the Opioid Epidemic Using Data To Inform Policy and Programs Monica Bharel, MD MPH Commissioner of Public Health Data For Massachusetts 2017 Q2 Quarterly Report and Chapter 55

More information

Opioid Review and MAT Clinic CDC Guidelines

Opioid Review and MAT Clinic CDC Guidelines 1 Opioid Review and MAT Clinic CDC Guidelines January 10, 2018 Housekeeping Use chat feature to inform everyone who s at your clinic Click chat on Zoom option bar Chat Everyone the names of those who are

More information

OPIOIDS IN JACKSON COUNTY A PUBLIC HEALTH PERSPECTIVE OPIOID AWARENESS COUNTY LEADERSHIP FORUM SHELLEY CARRAWAY, HEALTH DIRECTOR DATE

OPIOIDS IN JACKSON COUNTY A PUBLIC HEALTH PERSPECTIVE OPIOID AWARENESS COUNTY LEADERSHIP FORUM SHELLEY CARRAWAY, HEALTH DIRECTOR DATE OPIOIDS IN JACKSON COUNTY A PUBLIC HEALTH PERSPECTIVE OPIOID AWARENESS COUNTY LEADERSHIP FORUM SHELLEY CARRAWAY, HEALTH DIRECTOR DATE LOCAL HEALTH DIRECTOR REGIONS For counties with low counts, regional

More information

New Jersey Mental Health and Addiction Providers Meeting April 26, Shereef Elnahal, M.D., M.B.A. Commissioner New Jersey Department of Health

New Jersey Mental Health and Addiction Providers Meeting April 26, Shereef Elnahal, M.D., M.B.A. Commissioner New Jersey Department of Health New Jersey Mental Health and Addiction Providers Meeting April 26, 2018 Shereef Elnahal, M.D., M.B.A. Commissioner New Jersey Department of Health DOH Healthcare & Public Health Priorities Reduce disparities

More information

Welcome - we will begin the webinar shortly Please read the participation tips below:

Welcome - we will begin the webinar shortly Please read the participation tips below: Welcome - we will begin the webinar shortly Please read the participation tips below: All guest phones have been muted: Background noises, conversations, white noise etc., can be disruptive to a webinar.

More information

Economic Costs of Substance Abuse Dheeraj Raina, MD

Economic Costs of Substance Abuse Dheeraj Raina, MD Economic Costs of Substance Abuse Dheeraj Raina, MD Medical Director, Anthem Annual U.S. Economic Cost of Substance Use Disorders (SUD) In $ (millions) $168 Healthcare $26 $11 $27 $79 $193 $249 $300 Crime

More information

NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse

NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse Virtually All of the U.S. Have Increased Drug Overdoses:

More information

6/6/2017. First Do No Harm SECTION 1 THE OPIOID CRISIS. Implementing an Opioid Stewardship Program in a HealthCare System OBJECTIVES

6/6/2017. First Do No Harm SECTION 1 THE OPIOID CRISIS. Implementing an Opioid Stewardship Program in a HealthCare System OBJECTIVES First Do No Harm Implementing an Opioid Stewardship Program in a HealthCare System Phil Chang, MD Kristy Deep, MD Doug Oyler, PharmD June 12, 2017 OBJECTIVES Explain the role of opioid stewardship as a

More information

California Hub and Spoke System Evaluation

California Hub and Spoke System Evaluation California Hub and Spoke System Evaluation Darren Urada, Ph.D. and Howard Padwa, Ph.D. UCLA Integrated Substance Abuse Programs August 23, 2016 Substance Use Disordeers Statewide Conference Pomona, CA

More information

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division

The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division The Oregon Opioid Initiative State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division Disclosure No disclosures 2 Learning Objectives Learner will be able

More information

Alamance County Leadership Forum Follow-up Report

Alamance County Leadership Forum Follow-up Report Alamance County Leadership Forum Follow-up Report On December 8, 2017, a County Leadership Forum on Opioid Abuse was held in Alamance County. Established by the North Carolina Association of County Commissioners,

More information

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D.

Linking Opioid Treatment in Primary Care. Roxanne Lewin M.D. Roxanne Lewin M.D. The Facts Fewer than 10 percent of individuals with an alcohol use disorder and only about 20 percent of individuals with an opioid use disorder receive specialty treatment. Many individuals

More information

Creating a Structure for Success: Humboldt Opioid Safety Coalition. Mary Meengs, MD, Medical Director Rosemary DenOuden, Chief Operating Officer

Creating a Structure for Success: Humboldt Opioid Safety Coalition. Mary Meengs, MD, Medical Director Rosemary DenOuden, Chief Operating Officer Creating a Structure for Success: Humboldt Opioid Safety Coalition Mary Meengs, MD, Medical Director Rosemary DenOuden, Chief Operating Officer Behind the Redwood Curtain Remote, sparsely populated 135K

More information

Potential Solutions to Epidemic Substance Abuse in US and Europe

Potential Solutions to Epidemic Substance Abuse in US and Europe Potential Solutions to Epidemic Substance Abuse in US and Europe Richard C. Dart, MD, PhD Director, Rocky Mountain Poison and Drug Center, Denver Health 1 Professor, University of Colorado School of Medicine

More information

Treatment Gaps in Opioid-Agonist Medication Assisted Therapy (OA-MAT) in California Counties: How Many Additional Prescribers Are Needed?

Treatment Gaps in Opioid-Agonist Medication Assisted Therapy (OA-MAT) in California Counties: How Many Additional Prescribers Are Needed? Treatment Gaps in Opioid-Agonist Medication Assisted Therapy (OA-MAT) in California Counties: How Many Additional Prescribers Are Needed? Lisa Clemans-Cope, Marni Epstein, Doug Wissoker (Urban Institute)

More information

EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS

EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS EXECUTIVE ORDER TAKING FURTHER ACTIONS TO ADDRESS THE OPIOID OVERDOSE CRISIS Gina M. Raimondo, Governor Nicole Alexander-Scott, MD, MPH, Director of Health Action Plan Strategies to Date Since 2015, we

More information

Understanding the Opiate Epidemic

Understanding the Opiate Epidemic Understanding the Opiate Epidemic An opiate is a narcotic analgesic that depresses the central nervous system. Natural opiates are derived from the poppy plant. Synthetic opiates are manufactured drugs

More information

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists

Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists CENTERS FOR MEDICARE & MEDICAID SERVICES Medicare Part D Prescription Opioid Policies for 2019 Information for Pharmacists Background Opioid medications are effective at treating certain types of pain,

More information

DHCS Tribal MAT Project

DHCS Tribal MAT Project DHCS Tribal MAT Project Melissa Eidman & Valentine Antony California Consortium for Urban Indian Health August 2018 CaliforniaConsortiumforUrbanIndianHealth CCUIH StrengtheningTheOrganizationsThatStrengthenOurCommunities

More information

DPH programs related to opioid use disorder. Judith Martin, MD Medical Director of Substance Use Services SFDPH

DPH programs related to opioid use disorder. Judith Martin, MD Medical Director of Substance Use Services SFDPH DPH programs related to opioid use disorder Judith Martin, MD Medical Director of Substance Use Services SFDPH Opioid safety, SF timeline Opioid agonist treatment: methadone Seven clinics contract with

More information

SC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC

SC MAT ACCESS. Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC SC MAT ACCESS Medication Assisted Treatment Academic Community Capacity Expansion for Sustainable Success Kathleen Brady, MD, PhD, VPR, MUSC Overdose Death Rates from Opiates Most important sign of a

More information

Fighting Today s Opioid Epidemic

Fighting Today s Opioid Epidemic Fighting Today s Opioid Epidemic Establish in 1966 as a Public Health Department Location: Rock Falls, IL/Whiteside County Population: Whiteside County 2015--57,079 Serving Rural IL: Primarily Whiteside,

More information

OUD & MAR: Caring for Our Communities

OUD & MAR: Caring for Our Communities OUD & MAR: Caring for Our Communities Speaker: Elisabeth Fowlie Mock, MD, MPH Video Resources Diversion Alert/recoveryinme video https://www.youtube.com/watch?v=q1lsmwwwm40 CDC Videos RX Awareness Campaign

More information

Oregon Opioid Overdose Prevention Initiative

Oregon Opioid Overdose Prevention Initiative Oregon Opioid Overdose Prevention Initiative Katrina Hedberg, MD, MPH Health Officer & State Epidemiologist Oregon Public Health Division Oregon Association of Hospitals & Health Systems February 2017

More information

Progress Report and 2018 Legislative Opportunities. Maine Opiate Collaborative Recommendations

Progress Report and 2018 Legislative Opportunities. Maine Opiate Collaborative Recommendations Progress Report and 2018 Legislative Opportunities related to the Maine Opiate Collaborative Recommendations April 2018 A. Destigmatize substance use disorders within the law enforcement profession 1.

More information

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016 What Science Says about Opioid Use Disorder and Its Treatment Perilou Goddard, Ph.D. Department of Psychological Science Northern Kentucky University Examples of Opioids Agonists (activate opioid receptors)

More information

Mission: The Oregon Coalition for Responsible Use of Meds (OrCRM) is a Statewide Coalition launched to prevent overdose, misuse and abuse of

Mission: The Oregon Coalition for Responsible Use of Meds (OrCRM) is a Statewide Coalition launched to prevent overdose, misuse and abuse of Mission: The Oregon Coalition for Responsible Use of Meds (OrCRM) is a Statewide Coalition launched to prevent overdose, misuse and abuse of amphetamines and opioids, both prescription and illicit, among

More information

Harold Rogers Update Melissa McPheeters, PhD, MPH

Harold Rogers Update Melissa McPheeters, PhD, MPH Harold Rogers Update 2017 Melissa McPheeters, PhD, MPH We Need a New Normal Full collaboration among diverse departments Appropriate integration of data from disparate data sources Business intelligence

More information

The Opioid Crisis in Minnesota: On the Ground Approaches. Laura Palombi, PharmD, MPH, MAT, AE-C Heather Blue, PharmD, BCPS, BCGP

The Opioid Crisis in Minnesota: On the Ground Approaches. Laura Palombi, PharmD, MPH, MAT, AE-C Heather Blue, PharmD, BCPS, BCGP The Opioid Crisis in Minnesota: On the Ground Approaches Laura Palombi, PharmD, MPH, MAT, AE-C Heather Blue, PharmD, BCPS, BCGP Objectives Describe current pharmacy practices to address the opioid crisis

More information

The State of Substance Misuse and Addiction: Secondary Prevention Strategies. June 1, :00 pm 3:00 pm ET Audio: ;

The State of Substance Misuse and Addiction: Secondary Prevention Strategies. June 1, :00 pm 3:00 pm ET Audio: ; The State of Substance Misuse and Addiction: Secondary Prevention Strategies June 1, 2017 2:00 pm 3:00 pm ET Audio: 888-378-4398; 555512 Dr. Jay Butler, MD, CPE Chief Medical Officer Alaska Department

More information

STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A.

STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A. STATE & FEDERAL EFFORTS TO COMBAT THE OPIOID EPIDEMIC & IMPACT ON COMPLIANCE PROGRAMS GRACE E. REBLING OSBORN MALEDON P.A. Arizona Corporate Counsel Presentation May 8, 2018 Agenda 1. Overview of the Opioid

More information

Medication-Assisted Treatment. What Is It and Why Do We Use It?

Medication-Assisted Treatment. What Is It and Why Do We Use It? Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite

More information

Prescription Drug Abuse Task Force Rx Report Card

Prescription Drug Abuse Task Force Rx Report Card San Diego County Prescription Drug Abuse Task Force 2016 Rx Report Card October 2016 Key Measures of Prescription Drug and Heroin Problems in San Diego County. Visit www.sandiegorxabusetaskforce.org for

More information

A Community Response to a Community Crisis

A Community Response to a Community Crisis A Community Response to a Community Crisis Prevention Intervention Treatment Recovery Factors that Affect Health Public Health Pyramid Smallest Impact Largest Impact Counseling and Education Clinical Interventions

More information

Latest Research on Addiction and Treatment

Latest Research on Addiction and Treatment Latest Research on Addiction and Treatment Joshua D Lee MD MSc joshua.lee@nyumc.org / @DrJoshuaDLee Associate Professor NYU School of Medicine, Department of Population Health Disclosures, LeeJD Grants:

More information

Kansas Prescription Drug and Opioid Advisory Committee

Kansas Prescription Drug and Opioid Advisory Committee Kansas Prescription Drug and Opioid Advisory Committee Vision: To build capacity, mobilize resources, and enhance the quality and availability of data to support data-driven strategic planning at the state

More information

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates What is MAT? Medication Assisted Treatment (MAT) is the use of medications, in addition to counseling, cognitive behavioral

More information

A Systems Approach to the Opioid Crisis Safina Koreishi, MD, MPH Mara Laderman, MSPH Lindsay Martin, MSPH

A Systems Approach to the Opioid Crisis Safina Koreishi, MD, MPH Mara Laderman, MSPH Lindsay Martin, MSPH A26/B26 These presenters have nothing to disclose A Systems Approach to the Opioid Crisis Safina Koreishi, MD, MPH Mara Laderman, MSPH Lindsay Martin, MSPH December 6, 2016 9:30 10:45 AM 11:15 AM 12:30

More information

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities

Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Identification of Specific Drugs and Drug Diversion in Drug Overdose Fatalities Svetla Slavova, PhD Sara LaMantia, MS Terry Bunn, PhD Tracey Corey, MD 2016 Safe States Annual Meeting April 13, 2016, Albuquerque,

More information

Implementing Pain and Opioid Management Guidelines in Primary Care Practice

Implementing Pain and Opioid Management Guidelines in Primary Care Practice Implementing Pain and Opioid Management Guidelines in Primary Care Practice Objectives 1. What is the issue? 2. Why use a dedicated dissemination & implementation process? a. Historical perspective Cooperative

More information

HARM REDUCTION & TREATMENT. Devin Reaves MSW

HARM REDUCTION & TREATMENT. Devin Reaves MSW HARM REDUCTION & TREATMENT Devin Reaves MSW The mission of PAHRC is to promote the health, dignity, and human rights of individuals who use drugs and communities impacted by drug use. Recognizing that

More information

Combating the Opiate Crisis in Ohio

Combating the Opiate Crisis in Ohio Combating the Opiate Crisis in Ohio In 2011, Gov. John R. Kasich announced the establishment of the Governor s Cabinet Opiate Action Team to fight opiate abuse in Ohio. Ohio is combating drug abuse through

More information

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction

Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, MD Co-Director, Opioid Policy Research Collaborative Heller School for Social Policy and Management Brandeis

More information

Opioid Use and Other Trends

Opioid Use and Other Trends Opioid Use and Other Trends National Overview Across the nation communities are struggling with a devastating increase in the number of people misusing opioid drugs, leading many to identify the current

More information

Data Driven Strategies

Data Driven Strategies Data Driven Strategies Full Task Force Meeting September 16, 2014 Review the problems Snapshot of local data Task Force goals Risk factors Breakout groups Prevention Intervention Treatment Recovery Words

More information

COUNTY OF SAN DIEGO. Opioid Update

COUNTY OF SAN DIEGO. Opioid Update COUNTY OF SAN DIEGO Opioid Update Linda Bridgeman Smith, DUI & Prevention Services Manager Health & Human Services Agency, Behavioral Health Services Co-chair, Prescription Drug Abuse Task Force 1 HEADLINES

More information

Vivitrol Drug Court and Medication Assisted Treatment

Vivitrol Drug Court and Medication Assisted Treatment Vivitrol Drug Court and Medication Assisted Treatment Amy Black, CNP and Judge Fred Moses Court program Self-starters Mission Statement To provide court-managed, medically assisted drug intervention treatment

More information

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery

SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery Page 1 of 9 SANTA BARBARA COUNTY DEPARTMENT OF Behavioral Wellness A System of Care and Recovery Departmental Polley and Procedure Section Sub-section Alcohol and Drug Program (ADP) Effective: 7/11/2018

More information

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 NORTHWEST AIDS EDUCATION AND TRAINING CENTER Opioid Use Disorders Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 Opioid Use Disorders Importance of opioid use disorders Screening and

More information

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.

The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin. The Wisconsin Prescription Drug Monitoring Program Wisconsin Nurses Association Jail Health Care Conference May 21, 2018 WI PDMP Timeline PDMP Overview January 2013 WI PDMP operational April 2017 WI epdmp

More information

How are Maryland Schools Addressing the Heroin / Opioid Epidemic?

How are Maryland Schools Addressing the Heroin / Opioid Epidemic? How are Maryland Schools Addressing the Heroin / Opioid Epidemic? 22 nd Advancing School Mental Health Conference October 19, 2017 Reginald Burke, Specialist School Completion and Alternative Programs

More information

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine

Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine Building a Comprehensive, Community-driven Prevention Approach to the Opioid Crisis in Maine Scott M. Gagnon, MPP, PS-C Director, AdCare Educational Institute of Maine, Inc. Co-Chair, Prevention & Harm

More information

Lessons from the First Year Implementing A Local Prescription Drug Abuse Coalition. Matt Willis, MD MPH Public Health Officer Marin County

Lessons from the First Year Implementing A Local Prescription Drug Abuse Coalition. Matt Willis, MD MPH Public Health Officer Marin County Lessons from the First Year Implementing A Local Prescription Drug Abuse Coalition Matt Willis, MD MPH Public Health Officer Marin County What can we do as a community to prevent prescription drug misuse

More information

Building capacity for a CHC response to Ontario's Opioid Crisis

Building capacity for a CHC response to Ontario's Opioid Crisis Building capacity for a CHC response to Ontario's Opioid Crisis Rob Boyd Oasis Program Director Luc Cormier, RN, MScN Community Health Nurse Sandy Hill Community Health Centre #AOHC2016 @rboyd6 @SandyHillCHC

More information

Opioid Use Disorder Treatment Initiation in Diverse Settings

Opioid Use Disorder Treatment Initiation in Diverse Settings Opioid Use Disorder Treatment Initiation in Diverse Settings Sarah Wakeman, MD, FASAM Medical Director, Mass General Substance Use Disorder Initiative Assistant Professor, Harvard Medical School Disclosures

More information

Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse

Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse Implementing the 2017 President s Challenge: Primary, Secondary & Tertiary Prevention of Addiction & Substance Misuse Jay Butler, MD, President of ASTHO, Chief Medical Officer, Alaska Department of Health

More information

The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country

The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country Integrating Primary and Behavioral Health Care Through the Lens of Prevention July 14, 2016 New Orleans, Louisiana The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin

More information

BERNALILLO COUNTY OPIOID ABUSE ACCOUNTABILITY SUMMIT Turning the Curve on Opioid Abuse in Bernalillo County

BERNALILLO COUNTY OPIOID ABUSE ACCOUNTABILITY SUMMIT Turning the Curve on Opioid Abuse in Bernalillo County BERNALILLO COUNTY OPIOID ABUSE ACCOUNTABILITY SUMMIT Turning the Curve on Opioid Abuse in Bernalillo County NMPHA Annual Conference April 2, 2014 Marsha McMurray-Avila Coordinator, Bernalillo County Community

More information

Dr. Smith. Roneet Lev, MD FACEP Chief, Emergency Department Scripps Mercy Hospital Chair, San Diego Prescription Drug Abuse Medical Task Force

Dr. Smith. Roneet Lev, MD FACEP Chief, Emergency Department Scripps Mercy Hospital Chair, San Diego Prescription Drug Abuse Medical Task Force Dr. Smith Roneet Lev, MD FACEP Chief, Emergency Department Scripps Mercy Hospital Chair, San Diego Prescription Drug Abuse Medical Task Force 1 1 How We Got Here 2 The Epidemic 3 4 San Diego Death Diaries

More information

Opioids: What You Should Know About Opioid Prescribing. Denis G. Patterson, DO Nevada State Medical Association October 19, 2016

Opioids: What You Should Know About Opioid Prescribing. Denis G. Patterson, DO Nevada State Medical Association October 19, 2016 Opioids: What You Should Know About Opioid Prescribing Denis G. Patterson, DO Nevada State Medical Association October 19, 2016 Contact Information Denis G. Patterson, DO Nevada Advanced Pain Specialists

More information

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge HARM REDUCTION & THE OPIOID EPIDEMIC CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge NO OVERDOSE BATON ROUGE Formed in late 2013 Community education Naloxone distribution Syringe

More information

Community Engagement to Address the Opioid Crisis. Laura Palombi, PharmD, MPH, MAT, AE-C

Community Engagement to Address the Opioid Crisis. Laura Palombi, PharmD, MPH, MAT, AE-C Community Engagement to Address the Opioid Crisis Laura Palombi, PharmD, MPH, MAT, AE-C Presenter Information Assistant Professor at the University of Minnesota College of Pharmacy Affiliate Assistant

More information

FIGHTING ADDICTION AND IMPROVING BEHAVIORAL HEALTH

FIGHTING ADDICTION AND IMPROVING BEHAVIORAL HEALTH FIGHTING ADDICTION AND IMPROVING BEHAVIORAL HEALTH The Public Health Crisis of This Generation & Delaware s Plan for the Future Lt. Governor Bethany Hall-Long, Ph.D, RNC, FAAN INTRODUCTION BEHAVIORAL HEALTH

More information

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)

April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Nurse Practitioner Council New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) Peter Ryba, PharmD PMP Director

More information

Rural Prevention and Treatment of Substance Abuse Toolkit

Rural Prevention and Treatment of Substance Abuse Toolkit Rural Prevention and Treatment of Substance Abuse Toolkit September 18, 2017 Tricia Stauffer, MPH NORC Walsh Center for Rural Health Analysis Rural Health Outreach Tracking and Evaluation Program Funded

More information

From Medicaid Transformation Approved Project Toolkit, June 2017

From Medicaid Transformation Approved Project Toolkit, June 2017 From Medicaid Transformation Approved Project Toolkit, June 2017 Domain 3: Prevention and Health Promotion Transformation projects within this domain focus on prevention and health promotion to eliminate

More information

Community Partnerships in Upstream Behavioral Health Prevention

Community Partnerships in Upstream Behavioral Health Prevention Community Partnerships in Upstream Behavioral Health Prevention Adrienne Abbate, MPA Executive Director Staten Island Partnership for Community Wellness SIPCW is providing backbone support to the following

More information

Opiate Use among Ohio Medicaid Recipients

Opiate Use among Ohio Medicaid Recipients Opiate Use among Ohio Medicaid Recipients July 12, 2012 Ohio Colleges of Medicine Government Resource Center The Ohio State University College of Public Health Sponsored by The Ohio Department of Alcohol

More information

CHANGING CULTURE, BUILDING A SYSTEM, SUPPORTING PATIENTS AND STAFF. Andrew Suchocki, MD, MPH Medical Director Clackamas Health Centers

CHANGING CULTURE, BUILDING A SYSTEM, SUPPORTING PATIENTS AND STAFF. Andrew Suchocki, MD, MPH Medical Director Clackamas Health Centers CHANGING CULTURE, BUILDING A SYSTEM, SUPPORTING PATIENTS AND STAFF Andrew Suchocki, MD, MPH Medical Director Clackamas Health Centers DISCLOSURES None. OVERVIEW Basic description- context and system overview

More information